Treatment of severe, chronic hand eczema: results from a UK‐wide survey

@article{Smith2017TreatmentOS,
  title={Treatment of severe, chronic hand eczema: results from a UK‐wide survey},
  author={Isabelle L Smith and S. Brown and Jane Nixon and Fiona Cowdell and Steven J Ersser and Catherine Fernandez and Mark Goodfield and Cathy M. Green and P. J. Hampton and J. T. Lear and Catherine H Smith and L. Sunderland and Sandy Tubeuf and Miriam Wittmann},
  journal={Clinical and Experimental Dermatology},
  year={2017},
  volume={42}
}
Treatment of severe hand eczema (HE) that is resistant to topical potent corticosteroid treatment is challenging. In 2013, we surveyed 194 UK dermatologists to obtain information about their usual treatment pathways to inform the choice of the comparator in a trial of alitretinoin in severe HE (ALPHA trial); the results indicated that the treatment approaches favoured by UK dermatologists differ. Psoralen combined with ultraviolet A (PUVA) and alitretinoin were identified as the most frequent… Expand
5 Citations
Management of chronic hand and foot eczema. An Australia/New Zealand Clinical narrative
TLDR
Management of chronic hand/foot eczemas extends beyond mere pharmacological or physical treatment, and requires an encompassing approach including removal or avoidance of causative factors, behavioural changes and social support. Expand
Chronic hand eczema and hepatogenic pruritus with good response to apremilast
TLDR
This case is presented for the quick and complete response of HE with apremilast, and the effective control of hepatogenic pruritus, and a new possibility and alternative treatment of this complex and difficult of control with the treatments already described in the literature. Expand
Aldara‐induced dermatitis is associated with development of liver fibrosis in mice
TLDR
The authors argue that a more objective outcome like the Hand Eczema Severity Index (HECSI) might be a preferable alternative and processing the issues mentioned above, along with the limitations that the authors state in their discussion will contribute to the design of a more comprehensive and meaningful clinical trial. Expand
A pilot comparing ultraviolet modalities for hand eczema: shedding light on feasibility
TLDR
It is concluded that nutritional status usually, but not always, improves in patients with EB and some patients report better life quality even when growth parameters have worsened, perhaps reflecting the extreme burden of maintaining oral intake. Expand
An observer‐blinded randomized controlled pilot trial comparing localized immersion psoralen–ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema
Hand eczema is a common inflammatory dermatosis that causes significant patient morbidity. Previous studies comparing psoralen–ultraviolet A (PUVA) with narrowband ultraviolet B (NB‐UVB) have beenExpand

References

SHOWING 1-10 OF 10 REFERENCES
Consensus statement on the management of chronic hand eczema
TLDR
The epidemiology and pathogenesis of hand eczema, its diagnosis and its effect on patients’ quality of life are described, and recommendations for management are summarized in a treatment algorithm. Expand
Management of Chronic Hand Eczema.
TLDR
Switching from topical treatments should not be delayed to avoid sensitizations, time off work, and a negative impact on quality of life. Expand
Guidelines for topical PUVA: a report of a workshop of the British Photodermatology Group
TLDR
New guidelines for bath, local immersion and other topical PUVA are included and are based, where possible, on the results of controlled studies, or otherwise on the consensus view on current practice. Expand
Alitretinoin for the treatment of severe chronic hand eczema
TLDR
Alitretinoin has a favorable overall profile of adverse effects; however, female patients who are at risk of becoming pregnant should follow a strict pregnancy-prevention program due to the teratogenic effects of this drug. Expand
An overview of skin scores used for quantifying hand eczema: a critical update according to the criteria of evidence‐based medicine
TLDR
It is drawn that a standardized diagnostic procedure for assessing the severity of hand eczema would facilitate the comparability of outcome of clinical trials, and scoring systems used for occupational screening have to fulfil different demands compared with scoring system used for licensing of drugs. Expand
Overview of studies of treatments for hand eczema—the EDEN hand eczema survey
TLDR
A large number of interventions ranging from topical steroids to oral ciclosporin are used, but their evidence base and the best methods to assess their efficacy are uncertain. Expand
Hand eczema in Swedish adults - changes in prevalence between 1983 and 1996.
TLDR
The study indicates that the prevalence of hand eczema in Swedish adults had decreased between 1983 and 1996 despite an increasing prevalence of childhood Eczema, and a decreased occupational exposure to skin irritants is a probable cause. Expand
Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial
TLDR
A secondary prevention programme for hand eczema improved severity and quality of life and had a positive effect on self evaluated severity and skin protective behaviour by hand washings and wearing of protective gloves. Expand
Medical consultations in relation to severity of hand eczema in the general population
Background Hand eczema is a common disease with a wide severity spectrum. Little information exists concerning the association between the severity of hand eczema and medical consultations.
[Hand eczema].